From: Identification of target genes in cardiomyopathy with fibrosis and cardiac remodeling
rank | cmap name | Mean | n | enrichment | P-value |
---|---|---|---|---|---|
1 | tridihexethyl | −0.64 | 4 | − 0.883 | 0.00044 |
2 | Prestwick-682 | −0.509 | 4 | −0.848 | 0.00097 |
3 | fluoxetine | −0.494 | 4 | −0.806 | 0.00271 |
4 | pirlindole | −0.668 | 3 | −0.884 | 0.00312 |
5 | methyldopa | 0.382 | 5 | 0.732 | 0.00318 |
6 | ciclacillin | 0.494 | 4 | 0.789 | 0.00391 |
7 | sulfadiazine | 0.565 | 5 | 0.717 | 0.00409 |
8 | khellin | −0.418 | 5 | −0.708 | 0.00467 |
9 | PNU-0251126 | −0.358 | 6 | −0.656 | 0.00467 |
10 | metampicillin | 0.389 | 5 | 0.704 | 0.00537 |
11 | CP-645525-01 | −0.558 | 3 | −0.861 | 0.00553 |
12 | minoxidil | −0.446 | 5 | −0.694 | 0.00597 |
13 | spiradoline | −0.478 | 4 | −0.756 | 0.00718 |
14 | PHA-00816795 | −0.719 | 2 | −0.942 | 0.00722 |
15 | acenocoumarol | 0.509 | 5 | 0.687 | 0.00741 |
16 | cefotaxime | 0.561 | 5 | 0.682 | 0.00845 |
17 | metrizamide | 0.487 | 4 | 0.731 | 0.01044 |
18 | Y-27632 | −0.674 | 2 | −0.922 | 0.01223 |
19 | bacampicillin | −0.354 | 4 | −0.718 | 0.01271 |
20 | levocabastine | 0.274 | 4 | 0.718 | 0.01297 |